Published in J Neurochem on May 01, 1991
Proteasomes: multicatalytic proteinase complexes. Biochem J (1993) 2.08
The proteolytic fragments generated by vertebrate proteasomes: structural relationships to major histocompatibility complex class I binding peptides. Proc Natl Acad Sci U S A (1996) 1.15
Reaction of proteasomes with peptidylchloromethanes and peptidyldiazomethanes. Biochem J (1993) 0.86
Dry pea seed proteasome : purification and enzymic activities. Plant Physiol (1992) 0.84
Branched-chain-amino-acid-preferring peptidase activity of the lobster multicatalytic proteinase (proteasome) and the degradation of myofibrillar proteins. Biochem J (1995) 0.78
The effect of sodium chloride and temperature on the rate and extent of growth of Clostridium botulinum type A in pasteurized pork slurry. J Appl Bacteriol (1987) 2.91
Staging and natural history of cerebrovascular pathology in dementia. Neurology (2012) 2.61
Predicting microbial growth: the consequences of quantity of data. Int J Food Microbiol (1989) 2.01
A rapid method for preparing synaptosomes: comparison, with alternative procedures. Brain Res (1981) 1.85
Histochemical distribution of non-haem iron in the human brain. Acta Anat (Basel) (1992) 1.58
Purification and characterization of two soluble Cl(-)-activated arginyl aminopeptidases from human brain and their endopeptidase action on neuropeptides. J Neurochem (1988) 1.41
No evidence of an association between the T16189C mtDNA variant and late onset dementia. J Med Genet (2004) 1.40
Aluminosilicates and senile plaque formation in Alzheimer's disease. Lancet (1986) 1.35
Degradation of Alzheimer's beta-amyloid protein by human and rat brain peptidases: involvement of insulin-degrading enzyme. Neurochem Res (1997) 1.20
Metabolically active synaptosomes can be prepared from frozen rat and human brain. J Neurochem (1983) 0.99
Chronic postnatal DE-71 exposure: effects on learning, attention and thyroxine levels. Neurotoxicol Teratol (2008) 0.94
Nicotinic and muscarinic cholinergic receptor binding in the human hippocampal formation during development and aging. Brain Res Dev Brain Res (1997) 0.93
Polymerase chain reaction for detection of Clostridium botulinum types A, B and E in food, soil and infant faeces. J Appl Bacteriol (1994) 0.92
The substantia innominata and adjacent regions in the human brain: histochemical and biochemical observations. J Anat (1984) 0.92
Application of PCR to a clinical and environmental investigation of a case of equine botulism. J Clin Microbiol (1994) 0.90
Influence of the amyloid precursor protein locus on dementia in Down syndrome. Neurology (2004) 0.90
No association between the K variant of the butyrylcholinesterase gene and pathologically confirmed Alzheimer's disease. Hum Mol Genet (1998) 0.88
Characterization and determination of neuropeptides by high-performance liquid chromatography and radioimmunoassay. J Chromatogr (1981) 0.88
Aluminosilicates and the ageing brain: implications for the pathogenesis of Alzheimer's disease. Ciba Found Symp (1986) 0.88
Choosing life support for suddenly severely ill elderly relatives. Crit Care Resusc (2005) 0.86
Properties and possible significance of substance P and insulin fibrils. Neurosci Lett (1981) 0.85
N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) affects locomotor activity without producing a nigrostriatal lesion in the rat. Neurosci Lett (1984) 0.85
Medullary autonomic pathology in carotid sinus hypersensitivity. Neuropathol Appl Neurobiol (2007) 0.84
Involvement of endopeptidase 24.15 in the inactivation of bradykinin by rat brain slices. Biochem Biophys Res Commun (1987) 0.84
Comparison of the regional distribution of transferrin receptors and aluminium in the forebrain of chronic renal dialysis patients. J Neurol Sci (1989) 0.84
Brain iron homeostasis. J Inorg Biochem (1992) 0.84
Aluminium accumulation in relation to senile plaque and neurofibrillary tangle formation in the brains of patients with renal failure. J Neurol Sci (1992) 0.83
Aluminium accumulation, beta-amyloid deposition and neurofibrillary changes in the central nervous system. Ciba Found Symp (1992) 0.83
The role of the cholinergic system in the development of the human cerebellum. Brain Res Dev Brain Res (1995) 0.82
Estradiol enables cortisol to act directly upon the pituitary to suppress pituitary responsiveness to GnRH in sheep. Neuroendocrinology (2008) 0.81
Somatostatin immunoreactivity in cortical and some subcortical regions in Alzheimer's disease. J Neurol Sci (1985) 0.81
Removal of Arg1 and Phe22 from CLIP (ACTH18-39) by rodent pituitary and blood peptidases. Peptides (1989) 0.81
Purification and characterization of tripeptidylpeptidase-II from post-mortem human brain. Neurochem Res (1993) 0.81
Morphometry of the hippocampal microvasculature in post-stroke and age-related dementias. Neuropathol Appl Neurobiol (2014) 0.81
Characterization of corticotropin-like immunoreactive peptides in rat brain using high performance liquid chromatography. Neurosci Lett (1982) 0.81
The imaging and quantification of aluminium in the human brain using dynamic secondary ion mass spectrometry (SIMS). Biol Cell (1992) 0.80
Evidence for the early prenatal development of cortical cholinergic afferents from the nucleus of Meynert in the human foetus. Neurosci Lett (1985) 0.79
Human brain peptidase activity with the specificity to generate the N-terminus of the Alzheimer beta-amyloid protein from its precursor. Biochem Biophys Res Commun (1992) 0.79
Butyrylcholinesterase K: an association with dementia with Lewy bodies. Lancet (1998) 0.78
Neuropeptides in gliomas: identification of somatostatin 14 in a medulloblastoma. J Neurol Neurosurg Psychiatry (1986) 0.78
Thyrotrophin releasing hormone degradation by rat synaptosomal peptidases: production of the metabolite His-Pro. Neuropeptides (1988) 0.78
Degradation of Alzheimer's beta-amyloid protein by human cathepsin D. Neuroreport (1996) 0.78
Aggregation of A beta Alzheimer's disease-related peptide studied by dynamic light scattering. J Pept Res (1998) 0.78
The current status of the cortical cholinergic system in Alzheimer's disease and Parkinson's disease. Prog Brain Res (1986) 0.78
Medullary microvessel degeneration in multiple system atrophy. Neurobiol Dis (2007) 0.78
Role for aluminum and silicon in the pathogenesis of senile plaques: studies in chronic renal dialysis. Adv Neurol (1990) 0.77
Synaptosomes prepared from fresh human cerebral cortex; morphology, respiration and release of transmitter amino acids. Brain Res (1981) 0.77
An immunocytochemical study of the distribution of AMPA selective glutamate receptor subunits in the normal human motor system. Neuroscience (1996) 0.77
Degradation of luteinizing hormone-releasing hormone by serum and plasma in vitro. Regul Pept (1981) 0.77
Nitric oxide synthase gene polymorphisms in Alzheimer's disease and dementia with Lewy bodies. Neurosci Lett (2001) 0.76
The processing of Alzheimer A4/beta-amyloid protein precursor: identification of a human brain metallopeptidase which cleaves -Lys-Leu- in a model peptide. Biochem Biophys Res Commun (1991) 0.76
Use of post-mortem human synaptosomes for studies of metabolism and transmitter amino acid release. Neurosci Lett (1982) 0.76
Specificity of neuropeptide degradation by two calcium-activated neutral proteases from human skeletal muscle. Life Sci (1985) 0.76
Amorphous aluminosilicates promote nucleation of amyloid beta protein and tachykinins. Biochem Soc Trans (1993) 0.76
LRP gene and late-onset Alzheimer's disease. Lancet (1998) 0.75
Circulating antibody to myelin basic protein in relapsing-remitting multiple sclerosis? A comparative group and sequential study by radioimmunoassay. J Neurol Neurosurg Psychiatry (1978) 0.75
Weight reduction in obesity. Br Med J (1969) 0.75
Neuropeptide localisation in the substantia innominata and adjacent regions of the human brain. J Anat (1985) 0.75
Presenilin polymorphisms in Alzheimer's disease. Lancet (1997) 0.75
Ectopic corticotrophin-releasing-factor and growth hormone releasing factor secretion: diagnosis using human pituitary cell culture. Horm Res (1987) 0.75
Post mortem levels of thyrotropin-releasing hormone and neurotensin in the amygdala in Alzheimer's disease, schizophrenia and depression. J Neurol Sci (1983) 0.75
Chromatographic characterization of neuropeptides in post mortem human brain. J Neurol Sci (1984) 0.75
Some factors determining yields of peritoneal exudate macrophages from guinea pigs. Lab Anim Sci (1975) 0.75
Mechanism of luteinizing hormone-releasing hormone degradation by subcellular fractions of rat hypothalamus and pituitary. Regul Pept (1982) 0.75
Dipeptidylpeptidase IV initiates the degradation of neuropeptide Y in cardiac muscle membranes. Biochem Soc Trans (1992) 0.75
A comparison of the techniques of secondary ion mass spectrometry and resonance ionization mass spectrometry for the analysis of potentially toxic element accumulation in neural tissue. Rapid Commun Mass Spectrom (1997) 0.75
Human cerebellar cortex possesses high affinity binding sites for [3H]somatostatin. Eur J Pharmacol (1985) 0.75
Autoradiographic visualization of binding sites for [3H]somatostatin in the rat brain. Eur J Pharmacol (1987) 0.75
Molecular forms of somatostatin, substance P and neurotensin in fresh human cerebral cortex. Regul Pept (1986) 0.75
Identification of a human brain peptidase with the specificity to generate the N-terminus of A4/beta-amyloid protein from its precursor. Biochem Soc Trans (1992) 0.75
Dementia with Lewy bodies: no association of polymorphisms in the human synphilin gene. Neurogenetics (2004) 0.75
Human brain leucyl aminopeptidase: isolation, characterization and specificity against some neuropeptides. Neuropeptides (1991) 0.75
CADASIL and genetics of cerebral ischaemia. J Neural Transm Suppl (2002) 0.75
Effects of NOS inhibition on the cardiopulmonary system and brain microvascular markers after intermittent hypoxia in rats. Brain Res (2006) 0.75
Studies on the characterisation of alpha-MSH-like immunoreactivity in rat hypothalamus. Regul Pept (1983) 0.75
Corticotrophin-related peptides in the intermediate lobe of the rodent pituitary gland: characterization by high performance liquid chromatography and radioimmunoassay. Regul Pept (1982) 0.75
Alpha2-macroglobulin polymorphisms in Alzheimer's disease and dementia with Lewy bodies. Neuroreport (1999) 0.75
[Chemotherapy in advanced cancer of the lung]. Medicina (B Aires) (1980) 0.75
A preliminary study of plasma alpha MSH concentrations in depressed patients and normal subjects. Biol Psychiatry (1987) 0.75
Letter: Effect of prednisolone on lymphocyte transformation in multiple sclerosis. Lancet (1975) 0.75
Failure of gel filtration and HPLC purification to increase levels of immunoreactive TRH in rat brain extracts. Peptides (1984) 0.75
Raised thyrotrophin-releasing hormone, pyroglutamylamino peptidase, and proline endopeptidase are present in the spinal cord of wobbler mice but not in human motor neurone disease. J Neurochem (1987) 0.75
Stability of [D-Trp11]-neurotensin to rat brain peptidases. Neurosci Lett (1986) 0.75